Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
Frontiers in Genetics
|
September 21, 2018
Computational Tools for Splicing Defect Prediction in Breast/Ovarian Cancer Genes: How Efficient Are They at Predicting RNA Alterations?
Alejandro Moles-Fernández, Laura Duran-Lozano, Gemma Montalban, et al.
International Journal of Cancer
|
October 17, 2013
About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants
Sara Gutiérrez-Enríquez, Sandra Bonache, Gorka Ruíz de Garibay, et al.
Human Molecular Genetics
|
February 27, 2014
Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium
Mara Colombo, Marinus J Blok, Phillip Whiley, et al.
Human Mutation
|
July 12, 2019
Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variants
Melissa S Cline, Giulia Babbi, Sandra Bonache, et al.
EMBO Molecular Medicine
|
November 1, 2018
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
Marta Castroviejo-Bermejo, Cristina Cruz, Alba Llop-Guevara, et al.
Human Mutation
|
May 28, 2019
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
Michael T Parsons, Emma Tudini, Hongyan Li, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
Frontiers in Genetics
|
September 21, 2018
Computational Tools for Splicing Defect Prediction in Breast/Ovarian Cancer Genes: How Efficient Are They at Predicting RNA Alterations?
Alejandro Moles-Fernández, Laura Duran-Lozano, Gemma Montalban, et al.
International Journal of Cancer
|
October 17, 2013
About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants
Sara Gutiérrez-Enríquez, Sandra Bonache, Gorka Ruíz de Garibay, et al.
Human Molecular Genetics
|
February 27, 2014
Comprehensive annotation of splice junctions supports pervasive alternative splicing at the BRCA1 locus: a report from the ENIGMA consortium
Mara Colombo, Marinus J Blok, Phillip Whiley, et al.
Human Mutation
|
July 12, 2019
Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variants
Melissa S Cline, Giulia Babbi, Sandra Bonache, et al.
EMBO Molecular Medicine
|
November 1, 2018
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
Marta Castroviejo-Bermejo, Cristina Cruz, Alba Llop-Guevara, et al.
Human Mutation
|
May 28, 2019
Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification
Michael T Parsons, Emma Tudini, Hongyan Li, et al.
Page
of 3